RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Yasuhiro Yamamura to Viral Load

This is a "connection" page, showing publications Yasuhiro Yamamura has written about Viral Load.
Connection Strength

0.617
  1. Contreras-Galindo R, Gonz?lez M, Almodovar-Camacho S, Gonz?lez-Ram?rez S, Lorenzo E, Yamamura Y. A new Real-Time-RT-PCR for quantitation of human endogenous retroviruses type K (HERV-K) RNA load in plasma samples: increased HERV-K RNA titers in HIV-1 patients with HAART non-suppressive regimens. J Virol Methods. 2006 Sep; 136(1-2):51-7.
    View in: PubMed
    Score: 0.255
  2. S?nchez Mdel C, L?pez P, V?lez R, Yamamura Y. P-glycoprotein expression in HTLV-III cells after treatment with HIV-1 protease inhibitors. Ethn Dis. 2008; 18(2 Suppl 2):S2-60-4.
    View in: PubMed
    Score: 0.071
  3. Contreras-Galindo R, Almod?var-Camacho S, Gonz?lez-Ram?rez S, Lorenzo E, Yamamura Y. Comparative longitudinal studies of HERV-K and HIV-1 RNA titers in HIV-1-infected patients receiving successful versus unsuccessful highly active antiretroviral therapy. AIDS Res Hum Retroviruses. 2007 Sep; 23(9):1083-6.
    View in: PubMed
    Score: 0.070
  4. Contreras-Galindo R, L?pez P, V?lez R, Yamamura Y. HIV-1 infection increases the expression of human endogenous retroviruses type K (HERV-K) in vitro. AIDS Res Hum Retroviruses. 2007 Jan; 23(1):116-22.
    View in: PubMed
    Score: 0.067
  5. Anderson JC, Simonetti J, Fisher DG, Williams J, Yamamura Y, Rodriguez N, Sullivan DG, Gretch DR, McMahon B, Williams KJ. Comparison of different HCV viral load and genotyping assays. J Clin Virol. 2003 Sep; 28(1):27-37.
    View in: PubMed
    Score: 0.053
  6. Barrow GJ, Hylton-Kong T, Rodriguez N, Yamamura Y, Figueroa JP. HIV-1 drug resistance in treatment-naive chronically infected patients in Jamaica. Antivir Ther. 2013; 18(7):941-4.
    View in: PubMed
    Score: 0.025
  7. Ding M, Tarwater P, Rodriguez M, Chatterjee R, Ratner D, Yamamura Y, Roy P, Mellors J, Neogi D, Chen Y, Gupta P. Estimation of the predictive role of plasma viral load on CD4 decline in HIV-1 subtype C-infected subjects in India. J Acquir Immune Defic Syndr. 2009 Feb 01; 50(2):119-25.
    View in: PubMed
    Score: 0.019
  8. Kumar R, Perez-Casanova AE, Tirado G, Noel RJ, Torres C, Rodriguez I, Martinez M, Staprans S, Kraiselburd E, Yamamura Y, Higley JD, Kumar A. Increased viral replication in simian immunodeficiency virus/simian-HIV-infected macaques with self-administering model of chronic alcohol consumption. J Acquir Immune Defic Syndr. 2005 Aug 01; 39(4):386-90.
    View in: PubMed
    Score: 0.015
  9. Kumar R, Torres C, Yamamura Y, Rodriguez I, Martinez M, Staprans S, Donahoe RM, Kraiselburd E, Stephens EB, Kumar A. Modulation by morphine of viral set point in rhesus macaques infected with simian immunodeficiency virus and simian-human immunodeficiency virus. J Virol. 2004 Oct; 78(20):11425-8.
    View in: PubMed
    Score: 0.014
  10. Tirado G, Jove G, Kumar R, Noel RJ, Reyes E, Sepulveda G, Yamamura Y, Kumar A. Compartmentalization of drug resistance-associated mutations in a treatment-naive HIV-infected female. AIDS Res Hum Retroviruses. 2004 Jun; 20(6):684-6.
    View in: PubMed
    Score: 0.014
  11. Carlos MP, Yamamura Y, Vu Q, Conzen K, Anderson DE, Torres JV. Humoral immunity to immunodominant epitopes of Hepatitis C virus in individuals infected with genotypes 1a or 1b. Clin Immunol. 2004 Apr; 111(1):22-7.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support